Topical lidocaine for the treatment of postherpetic neuralgia

Cochrane Database of Systematic Reviews

Volumn , Issue 2, 2007, Pages

  Khaliq, Waqas ^a   Alam, S ^a   Puri, N ^a  

^a NONE

Author keywords

Administration, topical; Anesthetics, local *administration dosage ; Humans; Lidocaine *administration dosage ; Neuralgia, postherpetic *drug therapy

Indexed keywords

RETRACTED ARTICLE; REVIEW;

EID: 34748913770     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD004846.pub2     Document Type: Review

References (40)

1. Rowbotham 1995 {published data only} *Rowbotham MC, Davies PS, Fields HL. Topical Lidocaine Gel relieves post-herpetic neuralgia. Annals of Neurology 1995;37:246-53.
2. Rowbotham 1996a {published data only} *Rowbotham MC, Davies PS, Verkempinck C, Galer BS. Lidocaine patch: double-blind controlled study of a new treatment method for post-herpetic neuralgia. Pain 1996;65:39-44.
3. Rowbotham 1996b {published data only} *Rowbotham MC, Davies PS, Galer BS. Multicenter, double-blind, vehicle-controlled trial of long term use of lidocaine patches for postherpetic neuralgia (abstract). 8th World Congress on Pain - Abstracts. Seattle: IASP Press, 1996:274.
4. Galer 1999 *Galer BS, Rowbotham MC, Perander J, Friedman E. Topical lidocaine patch relieves postherpetic neuralgia more effectively than a vehicle topical patch: results of an enriched enrollment study. Pain 1999;80:533-8.
5. Galer 2002 Galer B, Jensen M, Ma T, Davies P, Rowbotham M. The lidocaine patch 5% effectively treats all neuropathic pain qualities: results of a randomised, double-blind, vehicle-controlled, 3-week efficacy study with the use of the neuropathic pain scale. The Clinical Journal of Pain 2002;18:297-301.
6. Iseki 2000 Iseki M, Mitsuhata H, Miyazaki T, Toriumi E, Yoshino K. Relief of subacute herpetic pain and postherpetic neuralgia with repeated application of 10% lidocaine cream. Masui 2000;49(11):1204-9.
7. Meier 2003 Meier T, Wasner G, Faust M, Kuntzer T, Ochsner F, Hueppe M, et.al. Efficacy of lidocaine patch 5% in the treatment of focal peripheral neuropathic pain syndromes: a randomised, double-blind, placebo-controlled study. Pain 2003;106:151-8.
8. Tajti 1999 Tajti J, Szok D, Vécsei L. Topical acetylsalicylic acid versus lidocaine for postherpetic neuralgia: results of a double-blind comparative clinical trial. Neurobiology (Budapest) 1999;7(2):103-8.
9. Tamakawa 1998 Tamakawa S, Ogawa H. Lidocaine tape (Penles - a dressing tape based on 60% lidocaine) reduces the pain of postherpetic neuralgia. Masui 1998;47(7):882-4.
10. Baranowski 1999 Baranowski AP, De Courcey J, Bonello E. A trial of intravenous lidocaine on the pain and allodynia of postherpetic neuralgia. Journal of Pain Symptom Management 1999;17(6):429-33.
11. Benett 1994 Benett GJ. Neuropathic pain. In: WallPD, MelzackR editor(s). Text-book of pain. 3rd Edition. Elsevier, 1994:201-24.
12. Chidiac 2001 Chidiac C, Bruxelle J, Daures JP, Hoang-Xuan T, Morel P, Leplege A, et al.Characteristics of patients with herpes zoster on presentation to practitioners in France. Clinical Infectious Diseases 2001;33:62-9.
13. Cluff 1998 Cluff RS, Rowbotham MC. Pain caused by herpes zoster infection. Neurologic Clinics 1998;16:813-32.
14. Comer 2000 Comer AM, Lamb HM. Lidocaine patch 5%. Drugs 2000;59:245-51.
15. Donahue 1995 Donahue JG, Choo PW, Manson JE, Platt R. The incidence of herpes zoster. Archives of Internal Medicine 1995;155:1605-9.
16. FDA 1999 US Food and Drug Administration: Center for Drug Evaluation & Research. Lidoderm (lidocaine) Patch Approval No. 20-619. http://www.fda.gov/cder/foi/nda/99/20612.htm (accessed: 12th June 2002) 1999.
17. Filadora 1999 Filadora VA, Sist TC, Lema MJ. Acute herpetic neuralgia and postherpetic neuralgia in the head and neck: response to gabapentin in five cases. Regional Anesthesia & Pain Medicine 1999;24:170-4.
18. Frucht-Pery 1997 Frucht-Pery J, Feldman ST, Brown SI. The use of capsaicin in herpes zoster ophthalmicus neuralgia. Acta Ophthalmologica Scandinavica 1997;75:311-3.
19. Galer 1997 Galer BS, Jensen MP. Development and preliminary validation of a pain measure specific to neuropathic pain: The neuropathic pain scale. Neurology 1997;48:332-8.
20. Graff-Radford 2000 Graff-Radford SB, Shaw LR, Naliboff BN. Amitriptyline and fluphenazine in the treatment of postherpetic neuralgia. Clinical Journal of Pain 2000;16:188-92.
21. Harke 2002 Harke H, Gretenkort P, Ladleif HU, Koester P, Rahman S. Spinal cord stimulation in postherpetic neuralgia and in acute herpes zoster pain. Anesthesia & Analgesia 2002;94:694-700.
22. Higgins 2005 Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions. Chichester, UK: John Wiley & Sons, Ltd, 4.2.5 [updated May 2005].
23. Lojeski 2000 Lojeski E, Stevens RA. Postherpetic neuralgia in the cancer patient. Current Review of Pain 2000;4:219-26.
24. MacDonald 2000 MacDonald BK, Cockerell OC, Sander JW, Shorvon SD. The incidence and lifetime prevalence of neurological disorders in a prospective community-based study in the UK. Brain 2000;123:665-76.
25. Meglio 1989 Meglio M, Cioni B, Rossi GF. Spinal cord stimulation in management of chronic pain: a 9-year experience. Journal of Neurosurgery 1989;70:519-24.
26. Pappagallo 1994 Pappagallo M, Campbell JN. Chronic opioid therapy as alternative treatment for post-herpetic neuralgia. Annals of Neurology 1994;35:S54-6.
27. Rice 2001 Rice AS, Maton S. Gabapentin in postherpetic neuralgia: a randomised, double blind, placebo controlled study. Pain 2001;94:215-24.
28. Rowbotham 1989 Rowbotham MC, Fields HL. Topical lidocaine reduces pain in postherpetic neuralgia. Pain 1989;38:297-301.
29. Rowbotham 1998a Rowbotham M, Petersen KL, Fields HL. Is post-herpetic neuralgia more than one disorder?. Pain Forum 1998;7:231-7.
30. Rowbotham 1998b Rowbotham M, Harden N, Stacey B, Bernstein P, Magnus-Miller L. Gabapentin for the treatment of postherpetic neuralgia: a randomized controlled trial. Journal of the American Medical Association 1998;280:1837-42.
31. Tremont-Lukats 2005 Tremont-Lukats IW, Teixeira GM, Backonja MM. Systemic administration of local anesthetic agents to relieve neuropathic pain. Cochrane Database of Systematic Reviews 2005, Issue 4.Art. No.: CD003345. DOI:10.1002/14651858.CD003345.pub2.
32. Tseng 2000 Tseng SH. Treatment of chronic pain by spinal cord stimulation. Journal of the Formosan Medical Association 2000;99:267-71.
33. Volmink 1996 Volmink J, Lancaster T, Gray S, Silagy C. Treatments for postherpetic neuralgia - a systematic review of randomized controlled trials. Family Practitioner 1996;13(1):84-91.
34. Wall 1991 Wall PD. Neuropathic pain and injured nerve: central mechanisms. British Medical Bulletin 1991;47:631-43.
35. Wasner 2005 G. Wasner, A. Kleinert, A. Binder, J. Schattschneider, R. Baron. Postherpetic neuralgia: Topical lidocaine is effective in nociceptor-deprived skin. Journal of Neurology 2005;252(6):677-86.
36. Watson 1991 Watson CPN, Deck JH, Morshead C, Van de Kooy D, Evans RJ. Post-herpetic neuralgia: further post-mortem studies of cases with and without post-herpetic neuralgia. Pain 1991;44:105-17.
37. Watson 1998a Watson CP, Babul N. Efficacy of oxycodone in neuropathic pain: a randomized trial in postherpetic neuralgia. Neurology 1998;50:1837-41.
38. Watson 1998b Watson CP, Vernich L, Chipman M, Reed K. Nortriptyline versus amitriptyline in postherpetic neuralgia: a randomized trial. Neurology 1998;51:1166-71.
39. Whitley 1998 Whitley RJ, Shukla S, Crooks RJ. The identification of risk factors associated with persistent pain following herpes zoster. Journal of Infectious Diseases 1998;178:S71-5.
40. Wiffen 2002 Wiffen P, Collins S, McQuay H, Carroll D, Jadad A, Moore A. Anticonvulsant drugs for acute and chronic pain. Cochrane Database of Systematic Reviews 2002, Issue 1.Art. No.: CD001133. DOI: 10.1002/14651858.CD001133.pub2.